• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·KPTI
Held by 1 Guru
Share

Karyopharm Therapeutics Inc. Stocks

$ 1.96Last Updated 21.08.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 44.31M

In Guru Portfolios

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.00%

Trending

24.08.2026 15:51

Morning in New York: Geopolitics and News from Nvidia Take Center Stage

24.08.2026 15:07

Nvidia is in talks to invest in Perplexity, with the AI startup valued at $30 billion, according to media reports

24.08.2026 13:49

Burry sold his Alibaba shares before the rights offering. At what price will he start buying again?

24.08.2026 12:43

Chinese tech stocks plummeted under pressure from Alibaba and YMTC's IPOs

24.08.2026 11:33

A Blow to the Dollar: Why the U.S. Effort to Support the Government Bond Market Failed to Convince Investors

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026